393 related articles for article (PubMed ID: 17195361)
1. [Severe neurological and obstetrical complications in a patient with antiphospholipid syndrome].
Bobrowska-Snarska D; Ostanek L; Nesterowicz B; Brzosko M
Pol Arch Med Wewn; 2006 May; 115(5):457-62. PubMed ID: 17195361
[TBL] [Abstract][Full Text] [Related]
2. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
4. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
5. [Following 90 patients with antiphospholipid syndrome with antibody titers and correlations with clinical manifestations: symptoms of the disease, a new antibody and correlations with clinical manifestations in the Israeli population].
Marai I; Levi Y; Godard G; Shoenfeld Y
Harefuah; 2001 Jun; 140(6):495-500, 565. PubMed ID: 11420848
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
7. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to beta2-glycoprotein I in systemic lupus erythematosus and primary antiphospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests.
Day HM; Thiagarajan P; Ahn C; Reveille JD; Tinker KF; Arnett FC
J Rheumatol; 1998 Apr; 25(4):667-74. PubMed ID: 9558167
[TBL] [Abstract][Full Text] [Related]
9. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
11. Antiphospholipid Syndrome with Antiβ2glicoprotein-1 Antibodies as the Cause of Recurrent Tibial Vein Thrombosis in SAPHO syndrome.
Przepiera-Będzak H; Brzosko M
Acta Dermatovenerol Croat; 2016 Dec; 24(4):305-306. PubMed ID: 28128085
[TBL] [Abstract][Full Text] [Related]
12. [Antiphospholipid syndrome : Update on diagnostics and management].
Specker C; Fischer-Betz R; Dörner T
Z Rheumatol; 2020 Apr; 79(3):255-266. PubMed ID: 32185464
[TBL] [Abstract][Full Text] [Related]
13. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid antibodies in high-risk pregnancy].
Nestorowicz B; Ostanek L; Ronin-Walknowska E; Fiedorowicz-Fabrycy I; Skoczowska M; Czajkowska E; Fischer K
Ginekol Pol; 2000 Jun; 71(6):500-8. PubMed ID: 11002552
[TBL] [Abstract][Full Text] [Related]
15. [Clinico-immunological aspects of antiphospholipid syndrome].
Reshetniak TM; Alekberova ZS; Aleksandrova EN
Vestn Ross Akad Med Nauk; 2003; (7):31-4. PubMed ID: 12934468
[TBL] [Abstract][Full Text] [Related]
16. [Spastic tetraparesis and heart thrombus in a male patient as first symptoms of the antiphospholipid syndrome].
Bobrowska-Snarska D; Ostanek L; Płońska E; Brzosko M
Ann Acad Med Stetin; 2006; 52 Suppl 2():75-9. PubMed ID: 17471840
[TBL] [Abstract][Full Text] [Related]
17. Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome.
Inanç M; Donohoe S; Ravirajan CT; Radway-Bright EL; Mackie I; Machin S; Isenberg DA
Br J Rheumatol; 1998 Oct; 37(10):1089-94. PubMed ID: 9825748
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus.
Woo KS; Kim KE; Kim JM; Han JY; Chung WT; Kim KH
Korean J Lab Med; 2010 Feb; 30(1):38-44. PubMed ID: 20197721
[TBL] [Abstract][Full Text] [Related]
19. Analysis of risk factors for the development of thrombotic complications in antiphospholipid antibody positive lupus patients.
Tarr T; Lakos G; Bhattoa HP; Shoenfeld Y; Szegedi G; Kiss E
Lupus; 2007; 16(1):39-45. PubMed ID: 17283584
[TBL] [Abstract][Full Text] [Related]
20. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).
Ordi-Ros J; Pérez-Pemán P; Monasterio J
Haemostasis; 1994; 24(3):165-74. PubMed ID: 7988946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]